Published in The Lancet · View the paper (DOI)
A large clinical trial in Latin America found a standard three-drug regimen for treating H. pylori more effective than four-drug regimens in Europe and Asia. The study, published in The Lancet, suggests that geographic variations in H. pylori resistance to antibiotics may account for the discrepancy.
Coverage from 2 institutions